NFKBIA and respiratory syncytial virus bronchiolitis: Polymorphic variants in the NFKBIA promoter are linked to an increased risk of hospitalization in severe RSV bronchiolitis and pulmonary hyperresponsiveness among children with respiratory viral infections identified within the first 12 months of life [80,81].